|
DUSP5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.356330E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.979800E-03 |
| Normal-vs-Stage2 |
7.192600E-04 |
| Normal-vs-Stage3 |
5.033900E-04 |
| Normal-vs-Stage4 |
8.778000E-03 |
| Stage1-vs-Stage2 |
1.996250E-01 |
| Stage1-vs-Stage3 |
1.255150E-01 |
| Stage1-vs-Stage4 |
7.677400E-01 |
| Stage2-vs-Stage3 |
8.694600E-01 |
| Stage2-vs-Stage4 |
5.161600E-01 |
| Stage3-vs-Stage4 |
5.565400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.350000E-04 |
| Normal-vs-AfricanAmerican |
1.390800E-01 |
| Normal-vs-Asian |
1.515020E-01 |
| Caucasian-vs-AfricanAmerican |
7.454100E-02 |
| Caucasian-vs-Asian |
5.660600E-01 |
| AfricanAmerican-vs-Asian |
7.922600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.361500E-04 |
| Normal-vs-Female |
1.369770E-02 |
| Male-vs-Female |
1.199720E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.995200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.421730E-03 |
| Normal-vs-Age(61-80Yrs) |
2.378700E-03 |
| Normal-vs-Age(81-100Yrs) |
7.584200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.775600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.191000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.522200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.863200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.466000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.277200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.938000E-01 |
| Normal-vs-Grade 2 |
5.035400E-03 |
| Normal-vs-Grade 3 |
1.434470E-04 |
| Normal-vs-Grade 4 |
3.700400E-02 |
| Grade 1-vs-Grade 2 |
4.283200E-01 |
| Grade 1-vs-Grade 3 |
5.767900E-02 |
| Grade 1-vs-Grade 4 |
7.134000E-01 |
| Grade 2-vs-Grade 3 |
5.779800E-03 |
| Grade 2-vs-Grade 4 |
8.295200E-01 |
| Grade 3-vs-Grade 4 |
1.565390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.010400E-04 |
| Normal-vs-ccB subtype |
6.375200E-03 |
| ccA subtype-vs-ccB subtype |
2.320200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.177700E-04 |
| Normal-vs-N1 |
4.859400E-03 |
| N0-vs-N1 |
8.418600E-01 |
|
|
